Company Overview and News

 
Reliance Jio offers: Rs 1,699 annual plan with 547 GB 4G data, 100% cashback on all recharges above Rs 100

15h moneycontrol
Telecom giant Reliance Jio has introduced a special annual prepaid recharge plan where it will provide users upto 547.5 GB 4G data at a price of Rs 1,699. The data plan will be valid for one year, where users will get 1.5 GB high-speed data everyday along with other benefits such as unlimited free voice calls, free messages and access to a plethora of exclusive Jio apps such as Jio Music, Jio TV among others.
WDC

19
73 Technology 'Safer' Dividend WallStars For October

2018-10-17 seekingalpha
WallStars all show positive broker target price upsides. Top "safer" dividend Technology WallStar, Western Digital, showed a 74.88% gain. Top-ten averaged 50.24% per Broker estimates plus dividends. 7/10 leaders were oversold.
WSO LRCX WSO.B CY KLIC WDC STX TEL MCHP KLAC AMAT GRMN DTST UMC QCOM MXIM

24
50 Top Technology Dividend WallStars By Yield And Gains For October

2018-10-17 seekingalpha
WallStars all show positive broker target price upsides. Top WallStar Technology ten by net gains, STX, XRX, KLAC, CY, LRCX, RELL, CAMT, WDC, TIVO and XPER, averaged 61.15%, calculated 10/15/18.
LRCX CY XPER RELLB WDC STX KLAC XRX CAMT LYTS UMC NOK RELL TESS TIVO

 
Western Digital (WDC) Gains As Market Dips: What You Should Know

2018-10-15 zacks
Western Digital (WDC - Free Report) closed at $54.50 in the latest trading session, marking a +0.17% move from the prior day. This change outpaced the S&P 500's 0.59% loss on the day. Elsewhere, the Dow lost 0.35%, while the tech-heavy Nasdaq lost 0.88%.
LMT VBTX WDC WSFS WSFSL

 
Implied Volatility Surging for Western Digital (WDC) Stock Options

2018-10-12 zacks
Investors in Western Digital Corporation (WDC - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Oct 19, 2018 $85.00 Call had some of the highest implied volatility of all equity options today.
WDC

 
WDC / Western Digital Corp. DEFA14A

2018-10-10 sec.gov
DEFA14A SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934
WDC

 
Western Digital (WDC) Dips More Than Broader Markets: What You Should Know

2018-10-08 zacks
Western Digital (WDC - Free Report) closed at $55.65 in the latest trading session, marking a -0.84% move from the prior day. This move lagged the S&P 500's daily loss of 0.04%. At the same time, the Dow added 0.15%, and the tech-heavy Nasdaq lost 0.67%.
FCN WDC

49
Fed Has To Be Careful - Cramer's Mad Money (10/3/18)

2018-10-04 seekingalpha - 2
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Wednesday, October 3.
AN CONE AMZN MU KMX WEED WDC CVNA CGC

33
Distraction-Free INTC Stock Is a Contrarian’s Dream

2018-10-02 investorplace
In one fell swoop, Intel (NASDAQ:INTC) reasserted itself back into the semiconductor discussion. For several months, all eyes zeroed in on Advanced Micro Devices (NASDAQ:AMD). Since the beginning of June, AMD has more than doubled. In sharp contrast, INTC stock has fallen nearly 17%.
WDC STX AMD INTC

 
Financial Exchange Stock Talk: Ranjit Thomas On Western Digital

2018-10-02 seekingalpha
We now partner with Financial Exchange Radio to produce a weekly segment with Seeking Alpha authors.
WDC

 
Western Digital (WDC) Stock Sinks As Market Gains: What You Should Know

2018-10-01 zacks
In the latest trading session, Western Digital (WDC - Free Report) closed at $58.02, marking a -0.94% move from the previous day. This move lagged the S&P 500's daily gain of 0.36%. At the same time, the Dow added 0.73%, and the tech-heavy Nasdaq lost 0.11%.
WDC EME

1
Top Analyst Upgrades and Downgrades: Amgen, Chipotle, Lam Research, Netgear, Teva Pharmaceutical, Western Digital and More

2018-10-01 247wallst - 1
The futures traded up big Monday morning as we start the final quarter of 2018. With some of the distractions starting to move out of the way, and the Federal Reserve rate increase on the books, Wall Street will be looking forward to the start of the third-quarter earnings reporting season. Add in Canada agreeing to a new trade deal, and stocks look ready to take off.
LOGM LRCX AMGN WDC TRI CIEN DLPH CMG NTGR

5
Micron is 'a better house in a tough neighborhood,' Mizuho says amid memory concerns

2018-10-01 marketwatch - 2
Mizuho analyst Vijay Rakesh defended Micron Technology Inc.'s MU, +0.53% stock on Monday, writing that the company was "a better house in a tough neighborhood" amid concerns about memory prices. Rakesh expects that DRAM prices could be down 3% or 4% in the calendar fourth quarter, but he predicts that prices could stabilize "earlier in the June quarter of 2018, providing a faster normalization for Micron.
LRCX MU WDC

 
Lam Research, Western Digital stocks fall after Mizuho downgrades

2018-10-01 marketwatch
Shares of Lam Research Corp. LRCX, +0.75% are down 0.5% in premarket trading Monday while shares of Western Digital Corp. WDC, +0.45% are down 1.1% after Mizhuo analyst Vijay Rakesh downgraded both stocks to neutral from buy due to NAND concerns. "We believe NAND ASP (average selling price) pricing will continue to decline at a low-double digit rate through 1Q19 and a high-single digit rate through 2019," he wrote.
LRCX WDC

12
Twitter stock worst performer on S&P 500 index; here’s how much its share price fell in third quarter

2018-10-01 financialexpress
Twitter Inc. just seized a title no company wants: the worst performer in the S&P 500 Index. Shares of the social-media giant dropped about 35 percent in third-quarter trading, which ended Friday — worse than every other company in the index. Twitter’s tough quarter was set off by a disappointing earnings report.
SQ SQNXF TWTR IPGP WDC

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to WDC / Western Digital Corp. on message board site Silicon Investor.

WDC, NAND, NVM, enterprise storage systems, etc. WDC, NAND, NVM, enterprise storage systems, etc. WDC, NAND, NVM, enterprise storage systems, etc. WDC/Sandisk Corporation WDC/Sandisk Corporation WDC/Sandisk Corporation
Western Digital (WDC) Western Digital (WDC) Western Digital (WDC) Disk Drive Sector Discussion Forum Disk Drive Sector Discussion Forum Disk Drive Sector Discussion Forum
WDC (Western Digital) -- Easy way to RICHES WDC (Western Digital) -- Easy way to RICHES WDC (Western Digital) -- Easy way to RICHES SHVA IBM (calls) PKGP WDC -new kid on the block SHVA IBM (calls) PKGP WDC -new kid on the block SHVA IBM (calls) PKGP WDC -new kid on the block
Disk Drives - Buy When BLOOD is in the street Disk Drives - Buy When BLOOD is in the street Disk Drives - Buy When BLOOD is in the street Western Digital Price Jump Western Digital Price Jump Western Digital Price Jump
CUSIP: 958102105